China Wholesale Astaxanthin Benefits Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our goal is usually to deliver high quality items at aggressive price ranges, and top-notch service to shoppers around the entire world. We're ISO9001, CE, and GS certified and strictly adhere to their high quality specifications for Uv Rays Sunscreen , Sun Protect Premia Spf 50 Lotion , Recommended Sunscreen , All products are manufactured with advanced equipment and strict QC procedures in order to ensure high quality. Welcome customers new and old to contact us for business cooperation.
China Wholesale Astaxanthin Benefits Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma Detail:

Product Paramete

Trade name UniAPI-PBS
CAS 1405-20-5
Product Name Polymyxin B sulfate
Appearance White or almost white powder
Solubility Water soluble
Application Medicine
Assay The sum of polymyxin B1, B2, B3 and B1-I: 80.0% minPolymyxin B3: 6.0% maxPolymyxin B1-I: 15.0% max
Package 1kg net per aluminum can
Shelf life 2 years
Storage Store in cool and dry place, away from light. 2~8℃ for storage.
Chemical Structure

Application

Polyxin B sulfate is a cationic surfactant antibiotic, a mixture of polyxin B1 and B2, which can improve the permeability of cell membrane. Almost odourless. Sensitive to light. Hygroscopic. Soluble in water, slightly soluble in ethanol.

Clinical effect

Its antibacterial spectrum and clinical application are similar to polymyxin e. it has inhibitory or bactericidal effects on Gram-negative bacteria, such as Escherichia coli, Pseudomonas aeruginosa, paraescherichia coli, Klebsiella pneumoniae, acidophilus, pertussis and dysentery. Clinically, it is mainly used for infection caused by sensitive bacteria, urinary system infection caused by Pseudomonas aeruginosa, eye, trachea, meningitis, sepsis, burn infection, skin and mucous membrane infection, etc

pharmacological action

It has antibacterial effect on Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Haemophilus, enterobacter, Salmonella, Shigella, pertussis, pasteurella and Vibrio. Proteus, Neisseria, Serratia, pruvidens, Gram-positive bacteria and obligate anaerobes were not sensitive to these drugs. There was cross resistance between this drug and polymyxin E, but there was no cross resistance between this drug and other antibiotics.

It is mainly used for wound, urinary tract, eye, ear, trachea infection caused by Pseudomonas aeruginosa and other Pseudomonas. It can also be used for sepsis and peritonitis.

 


Product detail pictures:

China Wholesale Astaxanthin Benefits Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate  – Uniproma detail pictures


Related Product Guide:

Our company since its inception, always regards product quality as enterprise life, continuously improve production technology, improve product quality and continuously strengthen enterprise total quality management, in strict accordance with the national standard ISO 9001:2000 for China Wholesale Astaxanthin Benefits Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma, The product will supply to all over the world, such as: Czech republic, Turkey, Seattle, Our solutions have national accreditation requirements for qualified, good quality items, affordable value, was welcomed by individuals all over the world. Our goods will continue to improve inside the order and appear forward to cooperation with you, Really should any of those items be of interest to you, please letus know. We will be satisfied to provide you a quotation up on receipt of the detailed needs.
  • High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
    5 Stars By Genevieve from Bulgaria - 2018.04.25 16:46
    The supplier abide the theory of "quality the basic, trust the first and management the advanced" so that they can ensure a reliable product quality and stable customers.
    5 Stars By Salome from Nicaragua - 2017.08.18 18:38